-
1دورية أكاديمية
المؤلفون: Kato, Takeshi, Kagawa, Yoshinori, Kuboki, Yasutoshi, Gamoh, Makio, Komatsu, Yoshito, Yasui, Hirofumi, Satake, Hironaga, Oki, Eiji, Tanioka, Hiroaki, Kotaka, Masahito, Makiyama, Akitaka, Denda, Tadamichi, Goto, Masahiro, Yoshino, Takayuki, Yamazaki, Kentaro, Soeda, Junpei, Shibuya, Kazunori, Iwata, Masaru, Oba, Koji, Yamaguchi, Kensei
المصدر: International Journal of Clinical Oncology; Jul2021, Vol. 26 Issue 7, p1238-1247, 10p
مصطلحات موضوعية: COLORECTAL cancer, METASTASIS, OVERALL survival, TREATMENT failure, PROGRESSION-free survival, PANITUMUMAB
-
2دورية أكاديمية
المؤلفون: Matsuoka, Hiroshi1 (AUTHOR), Kagawa, Yoshinori2 (AUTHOR), Ota, Mitsuyoshi3 (AUTHOR), Makiyama, Akitaka4 (AUTHOR), Akiyoshi, Kohei5 (AUTHOR), Denda, Tadamichi6 (AUTHOR), Matsuda, Chu7 (AUTHOR), Yamada, Yasuhide8 (AUTHOR), Morita, Satoshi9 (AUTHOR), Sakamoto, Junichi10 (AUTHOR), Muro, Kei11 (AUTHOR), Nakamura, Masato12 (AUTHOR), Kotaka, Masahito13 (AUTHOR), Nishina, Tmohiro14 (AUTHOR), Yabuno, Taichi15 (AUTHOR), Matsui, Takanori16 (AUTHOR), Iwasa, Satoru17 (AUTHOR), Kim, Tae Won18 (AUTHOR), Xu, Rui-Hua19 (AUTHOR), Park, Young Suk20 (AUTHOR)
المصدر: Annals of Oncology. 2019 Supplement 6, Vol. 30, pvi116-vi116. 1p.
مصطلحات موضوعية: *COLORECTAL cancer, *OVERALL survival, *METASTASIS, *PROGRESSION-free survival, *CANCER chemotherapy
-
3دورية أكاديمية
المؤلفون: Sunakawa, Yu1 (AUTHOR), Ichikawa, Wataru2 (AUTHOR), Hagiwara, Ken3 (AUTHOR), Tsuda, Masahiro4 (AUTHOR), Takagane, Akinori5 (AUTHOR), Yasui, Hisateru6 (AUTHOR), Satake, Hironaga6 (AUTHOR), Denda, Tadamichi7 (AUTHOR), Segawa, Yoshihiko8 (AUTHOR), Tanioka, Hiroaki9 (AUTHOR), Kotaka, Masahito10 (AUTHOR), Kochi, Mitsugu11 (AUTHOR), Watanabe, Takanori12 (AUTHOR), Nakamura, Masato13 (AUTHOR), Tsuji, Akihito14 (AUTHOR), Tani, Satoshi15 (AUTHOR), Negoro, Yuji16 (AUTHOR), Tobimatsu, Kazutoshi17 (AUTHOR), Takeuchi, Masahiro18 (AUTHOR), Fujii, Masashi19 (AUTHOR)
المصدر: Annals of Oncology. 2019 Supplement 6, Vol. 30, pvi97-vi97. 1p.
مصطلحات موضوعية: *COLORECTAL cancer, *CETUXIMAB, *OVERALL survival, *METASTASIS, *PROGRESSION-free survival